Clarivate officer proposes $165K share sale
The proposed shares are attributed to vesting of restricted stock and performance shares over periods extending from 2022 through 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Clarivate plc (CLVT) officer Jonathan Mark Collins filed notice of a proposed sale of 82,552 common shares, with an approximate sale date of November 3, 2026. Morgan Stanley Smith Barney LLC is listed as the broker, and the notice gives an aggregate market value of $165,351.66.
The shares were acquired upon vesting of 70,125 restricted stock shares during March 1, 2022 through March 15, 2026, and 12,427 performance shares during March 4, 2025 through February 18, 2026.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.